Skip to main content
Equibles

VIRTUS ADVISERS, LLC

Position in EXEL — Exelixis, Inc.

CIK 1587281 HARTFORD, CT
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$803,581
+$246,011 QoQ
Shares Held
14,769
+13.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#366
of 758 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VIRTUS ADVISERS, LLC holds $9,774,150 across 19 Biotechnology names. EXEL ranks #3 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACAD
Acadia Pharmaceuticals Inc
 44,384 $1,122,914
2 HRMY
Harmony Biosciences Holdings, Inc.
 29,253 $1,065,101
3 EXEL
Exelixis, Inc.
This page 		14,769 $803,581
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 9,249 $753,885
5 INVA
Innoviva, Inc.
 30,614 $695,243
6 VCEL
Vericel Corp
 15,570 $692,709
7 ROIV
Roivant Sciences Ltd.
 18,007 $637,267
8 SRPT
Sarepta Therapeutics, Inc.
 27,098 $486,950

All Filings in EXEL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $803,581 14,769
2026-03-31 $557,570 13,000
2025-12-31 $569,790 13,000
2025-09-30 $536,900 13,000
2025-06-30 $573,040 13,000
2025-03-31 $479,960 13,000
2024-12-31 $330,968 9,939
2024-09-30 $389,198 14,998
2024-06-30 $337,005 14,998
2024-03-31 $387,890 16,346
2023-12-31 $335,716 13,994
2023-09-30 $353,991 16,201
2023-06-30 $349,655 18,297
2023-03-31 $369,294 19,026
2022-12-31 $299,755 18,688
2022-09-30 $208,967 13,327
2022-06-30 $273,429 13,133
2022-03-31 $496,019 21,880
2021-12-31 $399,966 21,880
2021-09-30 $424,850 20,097
2021-06-30 $399,692 21,937
2021-03-31 $687,458 30,432
2020-12-31 $594,112 29,602
2020-09-30 $638,242 26,104
2020-06-30 $567,504 23,905
2020-03-31 $568,673 33,024